Autologous heart cell transplantation improves cardiac function after myocardial injury
- PMID: 10616980
- DOI: 10.1016/s0003-4975(99)01148-0
Autologous heart cell transplantation improves cardiac function after myocardial injury
Abstract
Background: Fetal ventricular cardiomyocyte transplantation into a cardiac scar improved ventricular function, but these cells were eventually eliminated by rejection. We therefore examined the feasibility of autologous adult heart cell transplantation.
Methods: A transmural scar was produced in the left ventricular free wall of adult rats by cryoinjury. The left atrial appendage was harvested, and the atrial heart cells were cultured and their number expanded ex vivo. Three weeks after cryoinjury, either a cell suspension (2 x 10(6) cells, n = 12 rats, transplant group) or culture medium (n = 10 rats, control group) was injected into the scar. Rats having a sham operation (n = 5) did not undergo cryoinjury or transplantation with cells or culture medium.
Results: Five weeks after injection, ventricular function was evaluated in a Langendorff preparation, measuring systolic, diastolic, and developed pressures over a range of intraventricular balloon volumes. Systolic and developed pressures were greater in the transplant group than in the control group (p = 0.0001). Rats with a sham operation had the greatest systolic, diastolic, and developed pressures (p = 0.0001). Histologic studies demonstrated survival of the transplanted heart cells within the scar. The area of the scar was smaller (p = 0.0003) and its thickness greater (p = 0.0003) in rats in the transplant group. Left ventricular chamber volume was smaller in the transplant group (p = 0.043).
Conclusions: Transplantation of autologous cultured adult atrial heart cells limited scar thinning and dilatation and improved myocardial function compared with results in control hearts. This technique may lead to a novel therapy to prevent scar expansion after a myocardial infarction and prevent the development of congestive heart failure.
Similar articles
-
Cardiomyocyte transplantation improves heart function.Ann Thorac Surg. 1996 Sep;62(3):654-60; discussion 660-1. doi: 10.1016/s0003-4975(96)00389-x. Ann Thorac Surg. 1996. PMID: 8783989
-
Fetal cell transplantation: a comparison of three cell types.J Thorac Cardiovasc Surg. 1999 Oct;118(4):715-24. doi: 10.1016/S0022-5223(99)70018-8. J Thorac Cardiovasc Surg. 1999. PMID: 10504639
-
Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury.Ann Thorac Surg. 2001 Dec;72(6):1957-63. doi: 10.1016/s0003-4975(01)03216-7. Ann Thorac Surg. 2001. PMID: 11789777
-
[Cardiomyocyte transplantation--a cell replacement for repair of myocardial infarction?].Z Kardiol. 1998 Jan;87(1):1-7. doi: 10.1007/s003920050147. Z Kardiol. 1998. PMID: 9531693 Review. German.
-
Cardiomyocyte transplantation into the failing heart-new therapeutic approach for heart failure?Heart Fail Rev. 2003 Jul;8(3):201-11. doi: 10.1023/a:1024796912475. Heart Fail Rev. 2003. PMID: 12878828 Review.
Cited by
-
N-Cadherin: structure, function and importance in the formation of new intercalated disc-like cell contacts in cardiomyocytes.Heart Fail Rev. 2000 Oct;5(3):251-7. doi: 10.1023/A:1009809520194. Heart Fail Rev. 2000. PMID: 16228908 Review.
-
Embryonic stem cells overexpressing Pitx2c engraft in infarcted myocardium and improve cardiac function.Int Heart J. 2009 Nov;50(6):783-799. doi: 10.1536/ihj.50.783. Int Heart J. 2009. PMID: 19952475 Free PMC article.
-
A review on experimental surgical models and anesthetic protocols of heart failure in rats.Front Vet Sci. 2023 Mar 27;10:1103229. doi: 10.3389/fvets.2023.1103229. eCollection 2023. Front Vet Sci. 2023. PMID: 37051509 Free PMC article. Review.
-
Human bone marrow-derived mesenchymal stem cells transplanted into damaged rabbit heart to improve heart function.J Zhejiang Univ Sci B. 2005 Apr;6(4):242-8. doi: 10.1631/jzus.2005.B0242. J Zhejiang Univ Sci B. 2005. PMID: 15754420 Free PMC article.
-
Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?Med Sci Monit Basic Res. 2013 Jan 14;19:20-31. doi: 10.12659/msmbr.883737. Med Sci Monit Basic Res. 2013. PMID: 23314418 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources